60 related articles for article (PubMed ID: 23285220)
1. Normative values of visual evoked potential in adults.
Ekayanti MS; Mahama CN; Ngantung DJ
Indian J Ophthalmol; 2021 Sep; 69(9):2328-2332. PubMed ID: 34427213
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intraoperative visual evoked potential amplitude reduction in predicting visual outcome after extended endoscopic endonasal resection of craniopharyngiomas.
Tao X; Fan X; Gui S; Liu J; Yang X; Li K; Yang J; Li C; Qiao H
J Neurosurg; 2024 May; 140(5):1270-1275. PubMed ID: 37948695
[TBL] [Abstract][Full Text] [Related]
3. Objective assessment of the human visual attentional state.
Willeford KT; Ciuffreda KJ; Yadav NK; Ludlam DP
Doc Ophthalmol; 2013 Feb; 126(1):29-44. PubMed ID: 23111658
[TBL] [Abstract][Full Text] [Related]
4. Ocular Findings of Cryptococcal Meningitis in Previously Healthy Adults.
Okeagu CU; Anjum SH; Vitale S; Wang J; Singh D; Rosen LB; Magone MT; Fitzgibbon EJ; Williamson PR
J Neuroophthalmol; 2023 Jun; 43(2):214-219. PubMed ID: 36255081
[TBL] [Abstract][Full Text] [Related]
5. Correlations between developmental test of visual perception-adolescent and adult and visual evoked potential in people with multiple sclerosis.
Rezaei Y; Akbarfahimi M; Azimian M; Mohaghegh F; Moghaddasi M
Curr J Neurol; 2020 Jul; 19(3):146-149. PubMed ID: 38011459
[No Abstract] [Full Text] [Related]
6. Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial.
McMurran CE; Mukherjee T; Brown JWL; Coles AJ; Cunniffe NG
Mult Scler; 2024 Mar; ():13524585241233177. PubMed ID: 38426437
[TBL] [Abstract][Full Text] [Related]
7. The visual evoked potential can save sight in patients with radiation-induced optic neuropathy.
Nouraeinejad A
Eur J Ophthalmol; 2021 Oct; ():11206721211049141. PubMed ID: 34664524
[TBL] [Abstract][Full Text] [Related]
8. Malignancy in the Public Life: The Story of Hubert Humphrey's Bladder Cancer.
Morris KE; Pappas TN
Urology; 2024 Mar; 185():54-58. PubMed ID: 38307326
[No Abstract] [Full Text] [Related]
9. Neuroimaging of Cryptococcal Meningitis in Patients without Human Immunodeficiency Virus: Data from a Multi-Center Cohort Study.
Anjum SH; Bennett JE; Dean O; Marr KA; Hammoud DA; Williamson PR
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233305
[TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term outcomes in patients with cryptococcal meningitis after ventriculoperitoneal shunt placement.
Wen J; Yin R; Chang J; Chen Y; Dong X; Cao W; Ma X; Li T; Wei J
Front Neurol; 2022; 13():773334. PubMed ID: 36468057
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Ngan NTT; Flower B; Day JN
Drugs; 2022 Aug; 82(12):1237-1249. PubMed ID: 36112342
[TBL] [Abstract][Full Text] [Related]
12. Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.
Molloy SF; Ross B; Kanyama C; Mfinanga S; Lesikari S; Heyderman RS; Kalata N; Ellis J; Kouanfack C; Chanda D; Temfack E; Lakhi S; Moodley A; Chan AK; van Oosterhout JJ; Mapoure Y; Mwaba P; Lalloo DG; Wang D; Lortholary O; Jaffar S; Hosseinipour MC; Loyse A; Harrison TS; Bicanic T
Open Forum Infect Dis; 2021 Apr; 8(4):ofab066. PubMed ID: 33937434
[TBL] [Abstract][Full Text] [Related]
13. Disseminated cryptococcosis in a HIV-negative patient: Case report of a newly diagnosed hypertensive adult presenting with hemiparesis.
Wilson RM; Moremi N; Mushi MF; Bader O; Ngoya PS; Desderius BM; Rambau P; Kabangila R; Groß U; Mshana SE
Med Mycol Case Rep; 2018 Dec; 22():4-7. PubMed ID: 30456162
[TBL] [Abstract][Full Text] [Related]
14. Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved.
Moodley A; Rae W; Bhigjee A
South Afr J HIV Med; 2015; 16(1):305. PubMed ID: 29568574
[TBL] [Abstract][Full Text] [Related]
15. Visual Disturbance in Patients with Cryptococcal Meningitis: The Road Ahead.
Kuriakose CK; Mishra AK; Vanjare HA; Raju A; Abraham OC
J Neurosci Rural Pract; 2017; 8(1):151-152. PubMed ID: 28149110
[No Abstract] [Full Text] [Related]
16. Pattern- and motion-related visual evoked potentials in HIV-infected adults.
Szanyi J; Kremlacek J; Kubova Z; Kuba M; Gebousky P; Kapla J; Szanyi J; Vit F; Langrova J
Doc Ophthalmol; 2017 Feb; 134(1):45-55. PubMed ID: 28074347
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.
Williamson PR; Jarvis JN; Panackal AA; Fisher MC; Molloy SF; Loyse A; Harrison TS
Nat Rev Neurol; 2017 Jan; 13(1):13-24. PubMed ID: 27886201
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis initially presenting with eye symptoms in an immunocompetent patient: A case report.
Li J; Wang P; Ye L; Wang Y; Zhang X; Yu S
Exp Ther Med; 2016 Aug; 12(2):1119-1124. PubMed ID: 27446330
[TBL] [Abstract][Full Text] [Related]
19. Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.
Moodley A; Rae W; Bhigjee A; Connolly C; Devparsad N; Michowicz A; Harrison T; Loyse A
PLoS One; 2012; 7(12):e52895. PubMed ID: 23285220
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
